These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31853893)

  • 1. A middle cerebral artery ischemic stroke occurring in a child with a large prolactinoma.
    Oh T; Amara D; Gupta N; Clerkin P
    Childs Nerv Syst; 2020 Apr; 36(4):853-856. PubMed ID: 31853893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
    Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA
    Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.
    Bettencourt-Silva R; Queirós J; Pereira J; Carvalho D
    J Med Case Rep; 2018 Dec; 12(1):360. PubMed ID: 30518416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric ischemic stroke from an apoplectic prolactinoma.
    Kasl RA; Hughes J; Burrows AM; Meyer FB
    Childs Nerv Syst; 2015 Aug; 31(8):1387-92. PubMed ID: 25948046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactinoma-associated headache and dopamine agonist treatment.
    Kallestrup MM; Kasch H; Østerby T; Nielsen E; Jensen TS; Jørgensen JO
    Cephalalgia; 2014 Jun; 34(7):493-502. PubMed ID: 24351278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucocele-like formation leading to neurological symptoms in prolactin-secreting pituitary adenomas under dopamine agonist therapy.
    Abe T; Lüdecke DK
    Surg Neurol; 1999 Sep; 52(3):274-9. PubMed ID: 10511086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.
    Strowd RE; Salvatori R; Laterra JJ
    J Oncol Pharm Pract; 2016 Jun; 22(3):517-22. PubMed ID: 25616657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed Pituitary Gangliocytoma and Prolactinoma Resistant to the Cabergoline Treatment.
    Yano S; Hide T; Uekawa K; Honda Y; Mikami Y; Kuratsu JI
    World Neurosurg; 2016 Nov; 95():620.e17-620.e22. PubMed ID: 27535625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report.
    Koguchi M; Nakahara Y; Ebashi R; Ogata A; Shimokawa S; Masuoka J; Abe T
    J Med Case Rep; 2019 Jan; 13(1):18. PubMed ID: 30660191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
    Kunasegaran S; Croxson MS; Holdaway I; Murphy R
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudotumor cerebri and prolactin secreting pituitary adenoma. Association or coincidence?
    Jamjoom BA; Sharab MA; Nasser TA; Jamjoom AB
    Neurosciences (Riyadh); 2010 Jul; 15(3):200-3. PubMed ID: 20831031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy.
    Vilar L; Czepielewsk MA; Naves LA; Rollin GA; Casulari LA; Coelho CE
    Endocr Pract; 2007; 13(4):396-402. PubMed ID: 17669717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactin-secreting microadenoma in menopausal women].
    Barka I; Dendana E; Chikhrouhou N; Maroufi A; Kacem M; Chadli M; Ach K
    Pan Afr Med J; 2017; 27():177. PubMed ID: 28904704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive reduction of tumour load and normalisation of hyperprolactinaemia after high dose cabergoline in metastasised prolactinoma causing thoracic syringomyelia.
    van Uum SH; van Alfen N; Wesseling P; van Lindert E; Pieters GF; Nooijen P; Hermus AR
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1489-91. PubMed ID: 15377706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary apoplexy within a macroprolactinoma.
    Watt A; Pobereskin L; Vaidya B
    Nat Clin Pract Endocrinol Metab; 2008 Nov; 4(11):635-41. PubMed ID: 18797434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report.
    Casulari LA; de Castro LF; Kessler IM; Mendonça JL; de Fátima Magalhães Gonzaga M
    J Med Case Rep; 2019 Jun; 13(1):183. PubMed ID: 31202268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of a child with a prolactin secreting macroadenoma with temozolomide.
    Felker J; Patterson B; Wrubel D; Janss A
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1413-1415. PubMed ID: 27815961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma.
    Knoepfelmacher M; Gomes MC; Melo ME; Mendonca BB
    Pituitary; 2004; 7(2):83-7. PubMed ID: 15761656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
    Soni A; De Silva SR; Allen K; Byrne JV; Cudlip S; Wass JA
    Pituitary; 2008; 11(3):307-11. PubMed ID: 17899387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.